Kezar Life Sciences Inc (NASDAQ:KZR)
| 2.78 BATS BZX Real-Time Price As of 12:40pm ET |  0.00 / 0.00%Today’s Change | 2.25 Today|||52-Week Range 11.02 | -60.51% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 154.0K | 175.0K | 690.0K | -- | ||
| Operating Expenses | Gross Income | -154.0K | -175.0K | -690.0K | -- | |
| General Expenses | 8.8M | 8.6M | 24.0M | -- | ||
| Research And Development | 7.4M | 6.5M | 18.1M | -- | ||
| Total Operating Expenses | 9.0M | 8.7M | 24.7M | -- | ||
| Non-Operating Expenses | Operating Income | -9.0M | -8.7M | -24.7M | -- | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -9.0M | -8.5M | -23.2M | -- | |
| Net Income | -9.0M | -8.5M | -23.2M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 19.1M | 19.1M | 10.3M | -- | |
| Shares To Calculate EPS Diluted | 19.1M | 19.1M | 10.3M | -- | ||
| Earnings Per Share | EPS | -$0.47 | -$0.45 | -$2.26 | -- | |
| EPS Diluted | -$0.47 | -$0.45 | -$2.26 | -- | ||
